标题
Oncogenic BRAF Alterations and Their Role in Brain Tumors
作者
关键词
-
出版物
Cancers
Volume 11, Issue 6, Pages 794
出版商
MDPI AG
发表日期
2019-06-10
DOI
10.3390/cancers11060794
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Targeting Molecular Pathways in Intracranial Metastatic Disease
- (2019) Vyshak Alva Venur et al. Frontiers in Oncology
- Gliosarcoma Is Driven by Alterations in PI3K/Akt, RAS/MAPK Pathways and Characterized by Collagen Gene Expression Signature
- (2019) Bartosz Wojtas et al. Cancers
- Genomic analysis demonstrates that histologically-defined astroblastomas are molecularly heterogeneous and that tumors with MN1 rearrangement exhibit the most favorable prognosis
- (2019) Norman L. Lehman et al. Acta Neuropathologica Communications
- Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial
- (2019) Ulrich Herrlinger et al. LANCET
- Multiplex ligation-dependent probe amplification analysis is useful for detecting a copy number gain of the FGFR1 tyrosine kinase domain in dysembryoplastic neuroepithelial tumors
- (2019) Nozomi Matsumura et al. JOURNAL OF NEURO-ONCOLOGY
- Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experience
- (2018) David Capper et al. ACTA NEUROPATHOLOGICA
- Molecularly defined diffuse leptomeningeal glioneuronal tumor (DLGNT) comprises two subgroups with distinct clinical and genetic features
- (2018) Maximilian Y. Deng et al. ACTA NEUROPATHOLOGICA
- Dabrafenib Treatment in a Patient with an Epithelioid Glioblastoma and BRAF V600E Mutation
- (2018) Garry Ceccon et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Recurrent papillary craniopharyngioma with BRAF V600E mutation treated with dabrafenib: case report
- (2018) Benjamin T. Himes et al. JOURNAL OF NEUROSURGERY
- Patterns of care and outcomes in gliosarcoma: an analysis of the National Cancer Database
- (2018) Jonathan Frandsen et al. JOURNAL OF NEUROSURGERY
- Concurrent BRAF/MEK Inhibitors in BRAF V600–Mutant High-Grade Primary Brain Tumors
- (2018) Karisa C. Schreck et al. Journal of the National Comprehensive Cancer Network
- Rapid Clinical and Radiographic Response With Combined Dabrafenib and Trametinib in Adults With BRAF -Mutated High-Grade Glioma
- (2018) Tanner M. Johanns et al. Journal of the National Comprehensive Cancer Network
- Desmoplastic Infantile Ganglioglioma/Astrocytoma (DIG/DIA) are Distinct Entities with Frequent BRAFV600 Mutations
- (2018) Anthony C Wang et al. MOLECULAR CANCER RESEARCH
- Clinicopathological and genetic association between epithelioid glioblastoma and pleomorphic xanthoastrocytoma
- (2018) Takuya Furuta et al. NEUROPATHOLOGY
- Review: Molecular characteristics of long-term epilepsy-associated tumours (LEATs) and mechanisms for tumour-related epilepsy (TRE)
- (2018) T. J. Stone et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Response to the BRAF/MEK inhibitors dabrafenib/trametinib in an adolescent with a BRAF V600E mutated anaplastic ganglioglioma intolerant to vemurafenib
- (2018) Asher M. Marks et al. PEDIATRIC BLOOD & CANCER
- The genetic landscape of ganglioglioma
- (2018) Melike Pekmezci et al. Acta Neuropathologica Communications
- Trametinib for progressive pediatric low-grade gliomas
- (2018) Maria Kondyli et al. JOURNAL OF NEURO-ONCOLOGY
- BRAF somatic mutation contributes to intrinsic epileptogenicity in pediatric brain tumors
- (2018) Hyun Yong Koh et al. NATURE MEDICINE
- Vemurafenib and cobimetinib overcome resistance to vemurafenib in BRAF-mutant ganglioglioma
- (2018) Mehdi Touat et al. NEUROLOGY
- BRAF kinase inhibitors for treatment of melanoma: developments from early-stage animal studies to Phase II clinical trials
- (2018) Taku Fujimura et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- BRAF Inhibition in BRAFV600-Mutant Gliomas: Results From the VE-BASKET Study
- (2018) Thomas Kaley et al. JOURNAL OF CLINICAL ONCOLOGY
- Review: Challenges in the histopathological classification of ganglioglioma and DNT: microscopic agreement studies and a preliminary genotype‐phenotype analysis
- (2018) I. Blümcke et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- KIAA1549-BRAF Expression Establishes a Permissive Tumor Microenvironment Through NFκB-Mediated CCL2 Production
- (2018) Ran Chen et al. NEOPLASIA
- Novel BRAF alteration in desmoplastic infantile ganglioglioma with response to targeted therapy
- (2018) Melissa M. Blessing et al. Acta Neuropathologica Communications
- BRAF V600E mutation is a significant prognosticator of the tumour regrowth rate in brainstem gangliogliomas
- (2017) Xin Chen et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Therapeutic and Prognostic Implications of BRAF V600E in Pediatric Low-Grade Gliomas
- (2017) Alvaro Lassaletta et al. JOURNAL OF CLINICAL ONCOLOGY
- Gliosarcomas with theBRAFV600E mutation: a report of two cases and review of the literature
- (2017) Leiming Wang et al. JOURNAL OF CLINICAL PATHOLOGY
- Report of effective trametinib therapy in 2 children with progressive hypothalamic optic pathway pilocytic astrocytoma: documentation of volumetric response
- (2017) Catherine Miller et al. Journal of Neurosurgery-Pediatrics
- A Phase 1/1b Study Evaluating Trametinib Plus Docetaxel or Pemetrexed in Patients With Advanced Non–Small Cell Lung Cancer
- (2017) David R. Gandara et al. Journal of Thoracic Oncology
- RARE-35. DABRAFENIB IN PATIENTS WITH RECURRENT, BRAF V600E MUTATED MALIGNANT GLIOMA AND LEPTOMENINGEAL DISEASE
- (2017) Michael Burger et al. NEURO-ONCOLOGY
- A brain-penetrant RAF dimer antagonist for the noncanonical BRAF oncoprotein of pediatric low-grade astrocytomas
- (2017) Yu Sun et al. NEURO-ONCOLOGY
- A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study
- (2017) Anuradha Banerjee et al. NEURO-ONCOLOGY
- Response in a child with a BRAF V600E mutated desmoplastic infantile astrocytoma upon retreatment with vemurafenib
- (2017) Cornelis M. van Tilburg et al. PEDIATRIC BLOOD & CANCER
- A new GTF2I-BRAF fusion mediating MAPK pathway activation in pilocytic astrocytoma
- (2017) Tajana Tešan Tomić et al. PLoS One
- Activating NRF1-BRAF and ATG7-RAF1 fusions in anaplastic pleomorphic xanthoastrocytoma without BRAF p.V600E mutation
- (2016) Joanna J. Phillips et al. ACTA NEUROPATHOLOGICA
- Germline and somatic FGFR1 abnormalities in dysembryoplastic neuroepithelial tumors
- (2016) Barbara Rivera et al. ACTA NEUROPATHOLOGICA
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- Vemurafenib in Metastatic Melanoma Patients with Brain Metastases: An Open-Label, Single-Arm, Phase 2, Multicentre Study
- (2016) GA McArthur et al. ANNALS OF ONCOLOGY
- Frequency of BRAF V600E mutations in 969 central nervous system neoplasms
- (2016) Felix Behling et al. Diagnostic Pathology
- Alterations in BRAF gene, and enhanced mTOR and MAPK signaling in dysembryoplastic neuroepithelial tumors (DNTs)
- (2016) Aanchal Kakkar et al. EPILEPSY RESEARCH
- Disseminated glioneuronal tumors occurring in childhood: treatment outcomes and BRAF alterations including V600E mutation
- (2016) Andrew J. Dodgshun et al. JOURNAL OF NEURO-ONCOLOGY
- Morphological and molecular features of astroblastoma, includingBRAFV600Emutations, suggest an ontological relationship to other cortical-based gliomas of children and young adults
- (2016) Norman L. Lehman et al. NEURO-ONCOLOGY
- Gliosarcomas lackBRAFV600Emutation, but a subset exhibit β-catenin nuclear localization
- (2016) Katherine E. Schwetye et al. NEUROPATHOLOGY
- Cutaneous Melanoma with Brain Metastasis: Report of 193 Patients with New Observations
- (2016) Alenka Gugger et al. PLoS One
- Establishment and application of a novel patient-derived KIAA1549:BRAF-driven pediatric pilocytic astrocytoma model for preclinical drug testing
- (2016) Florian Selt et al. Oncotarget
- Concurrent MEK targeted therapy prevents MAPK pathway reactivation during BRAFV600E targeted inhibition in a novel syngeneic murine glioma model
- (2016) Stefan Grossauer et al. Oncotarget
- Integrated analysis of pediatric glioblastoma reveals a subset of biologically favorable tumors with associated molecular prognostic markers
- (2015) Andrey Korshunov et al. ACTA NEUROPATHOLOGICA
- Pilocytic astrocytoma: pathology, molecular mechanisms and markers
- (2015) V. Peter Collins et al. ACTA NEUROPATHOLOGICA
- High rate of concurrent BRAF-KIAA1549 gene fusion and 1p deletion in disseminated oligodendroglioma-like leptomeningeal neoplasms (DOLN)
- (2015) Fausto J. Rodriguez et al. ACTA NEUROPATHOLOGICA
- BRAF VE1 Immunoreactivity Patterns in Epithelioid Glioblastomas Positive for BRAF V600E Mutation
- (2015) Bette K. Kleinschmidt-DeMasters et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Epithelioid Glioblastomas and Anaplastic Epithelioid Pleomorphic Xanthoastrocytomas-Same Entity or First Cousins?
- (2015) Sanda Alexandrescu et al. BRAIN PATHOLOGY
- Pilomyxoid Astrocytoma (PMA) Shows Significant Differences in Gene Expression vs. Pilocytic Astrocytoma (PA) and Variable Tendency Toward Maturation to PA
- (2015) Bette K. Kleinschmidt-DeMasters et al. BRAIN PATHOLOGY
- BRAF Mutants Evade ERK-Dependent Feedback by Different Mechanisms that Determine Their Sensitivity to Pharmacologic Inhibition
- (2015) Zhan Yao et al. CANCER CELL
- Analysis of IDH1-R132 mutation, BRAF V600 mutation and KIAA1549–BRAF fusion transcript status in central nervous system tumors supports pediatric tumor classification
- (2015) Midea Gierke et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Survival advantage combining a BRAF inhibitor and radiation in BRAF V600E-mutant glioma
- (2015) Tina Dasgupta et al. JOURNAL OF NEURO-ONCOLOGY
- BRAF Fusion Analysis in Pilocytic Astrocytomas: KIAA1549-BRAF 15-9 Fusions Are More Frequent in the Midline Than Within the Cerebellum
- (2015) Claire Faulkner et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Diagnostic, prognostic and predictive relevance of molecular markers in gliomas
- (2015) Sebastian Brandner et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Successful Retreatment of a Child with a Refractory Brainstem Ganglioglioma with Vemurafenib
- (2015) Dolly Aguilera et al. PEDIATRIC BLOOD & CANCER
- Molecular analysis of pediatric brain tumors identifies microRNAs in pilocytic astrocytomas that target the MAPK and NF-κB pathways
- (2015) Tania A. Jones et al. Acta Neuropathologica Communications
- Constitutive Activation of Raf-1 Induces Glioma Formation in Mice
- (2015) Yelena Lyustikman et al. NEOPLASIA
- Complete clinical regression of a BRAF V600E-mutant pediatric glioblastoma multiforme after BRAF inhibitor therapy
- (2014) Giles W Robinson et al. BMC CANCER
- Chromosome Band 7q34 Deletions Resulting inKIAA1549-BRAFandFAM131B-BRAFFusions in Pediatric Low-Grade Gliomas
- (2014) Jacquelyn J. Roth et al. BRAIN PATHOLOGY
- Pleomorphic Xanthoastrocytoma: Natural History and Long-Term Follow-Up
- (2014) Cristiane M. Ida et al. BRAIN PATHOLOGY
- Epithelioid glioblastoma arising from pleomorphic xanthoastrocytoma with the BRAF V600E mutation
- (2014) Shingo Tanaka et al. Brain Tumor Pathology
- New IDH1 I113T mutation associated with BRAF V600E mutation: New driver of gliomagenesis?
- (2014) E. Tabouret et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Response of recurrent BRAFV600E mutated ganglioglioma to Vemurafenib as single agent
- (2014) Francesca del Bufalo et al. Journal of Translational Medicine
- Oncogenic BRAF inhibitor UAI-201 induces cell cycle arrest and autophagy in BRAF mutant glioma cells
- (2014) Jun-Ho Ahn et al. LIFE SCIENCES
- Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas
- (2014) Priscilla K Brastianos et al. NATURE GENETICS
- Phase II study of sorafenib in children with recurrent or progressive low-grade astrocytomas
- (2014) M. A. Karajannis et al. NEURO-ONCOLOGY
- Autophagy Inhibition Improves Chemosensitivity in BRAFV600E Brain Tumors
- (2014) J. M. M. Levy et al. Cancer Discovery
- Posterior fossa and spinal gangliogliomas form two distinct clinicopathologic and molecular subgroups
- (2014) Kirti Gupta et al. Acta Neuropathologica Communications
- Mutant BRAF V600E protein in ganglioglioma is predominantly expressed by neuronal tumor cells
- (2013) Christian Koelsche et al. ACTA NEUROPATHOLOGICA
- BRAFV600E mutation is a negative prognosticator in pediatric ganglioglioma
- (2013) Sonika Dahiya et al. ACTA NEUROPATHOLOGICA
- Epithelioid GBMs Show a High Percentage of BRAF V600E Mutation
- (2013) Bette Kay Kleinschmidt-DeMasters et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Dysembryoplastic Neuroepithelial Tumors Share with Pleomorphic Xanthoastrocytomas and Gangliogliomas BRAFV600EMutation and Expression
- (2013) Céline Chappé et al. BRAIN PATHOLOGY
- Pediatric Brainstem Gangliogliomas ShowBRAFV600EMutation in a High Percentage of Cases
- (2013) Andrew M. Donson et al. BRAIN PATHOLOGY
- BRAF V600E Mutation Is Associated with mTOR Signaling Activation in Glioneuronal Tumors
- (2013) Avanita S. Prabowo et al. BRAIN PATHOLOGY
- Brainstem Ganglioglioma Successfully Treated With Vemurafenib
- (2013) Sarah Rush et al. JOURNAL OF CLINICAL ONCOLOGY
- Genome-Wide DNA Copy Number Analysis of Desmoplastic Infantile Astrocytomas and Desmoplastic Infantile Gangliogliomas
- (2013) Marco Gessi et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas
- (2013) NATURE GENETICS
- Paradoxical activation and RAF inhibitor resistance of BRAF protein kinase fusions characterizing pediatric astrocytomas
- (2013) A. J. Sievert et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Frequent BRAF Gain in Low-Grade Diffuse Gliomas with 1p/19q Loss
- (2012) Young-Ho Kim et al. BRAIN PATHOLOGY
- BRAF Alterations Are Frequent in Cerebellar Low-Grade Astrocytomas With Diffuse Growth Pattern
- (2012) Cristiane M. Ida et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial
- (2012) Axel Hauschild et al. LANCET
- Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial
- (2012) Georgina V Long et al. LANCET ONCOLOGY
- Phase I/II study of sorafenib in combination with temsirolimus for recurrent glioblastoma or gliosarcoma: North American Brain Tumor Consortium study 05-02
- (2012) E. Q. Lee et al. NEURO-ONCOLOGY
- Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody
- (2011) David Capper et al. ACTA NEUROPATHOLOGICA
- Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma
- (2011) Genevieve Schindler et al. ACTA NEUROPATHOLOGICA
- Genetic Aberrations Leading to MAPK Pathway Activation Mediate Oncogene-Induced Senescence in Sporadic Pilocytic Astrocytomas
- (2011) K. Jacob et al. CLINICAL CANCER RESEARCH
- BRAF Activation Induces Transformation and Then Senescence in Human Neural Stem Cells: A Pilocytic Astrocytoma Model
- (2011) E. H. Raabe et al. CLINICAL CANCER RESEARCH
- BRAF-KIAA1549 fusion transcripts are less frequent in pilocytic astrocytomas diagnosed in adults
- (2011) M. Hasselblatt et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- BRAF V600E Mutations Are Common in Pleomorphic Xanthoastrocytoma: Diagnostic and Therapeutic Implications
- (2011) Dora Dias-Santagata et al. PLoS One
- Combined molecular analysis of BRAF and IDH1 distinguishes pilocytic astrocytoma from diffuse astrocytoma
- (2009) Andrey Korshunov et al. ACTA NEUROPATHOLOGICA
- Activation of the ERK/MAPK pathway: a signature genetic defect in posterior fossa pilocytic astrocytomas
- (2009) Tim Forshew et al. JOURNAL OF PATHOLOGY
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
- (2009) Roger Stupp et al. LANCET ONCOLOGY
- Oncogenic RAF1 rearrangement and a novel BRAF mutation as alternatives to KIAA1549:BRAF fusion in activating the MAPK pathway in pilocytic astrocytoma
- (2009) D T W Jones et al. ONCOGENE
- Activated BRAF induces gliomas in mice when combined with Ink4a/Arf loss or Akt activation
- (2009) J P Robinson et al. ONCOGENE
- Tandem Duplication Producing a Novel OncogenicBRAFFusion Gene Defines the Majority of Pilocytic Astrocytomas
- (2008) David T.W. Jones et al. CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More